The Brazilian government has approved imports of cannabis-derived CBD oil for use in cancer treatment. The oil will be supplied by Medical Marijuana Inc.
During the last few years, Brazil has approved the state-funded CBD medication for such diseases and symptoms as Parkinsons, epilepsy, and chronic pain.
Stuart W. Titus, Ph.D. and CEO of Medical Marijuana, Inc. says that the company’s goal is “access for all.” At this point, their goal is to make cannabis-derived CBD available as oil, tinctures, capsules, and liquids legally available to those who need it.
Recent studies show that CBD may be effectively used as part of the treatment for rheumatoid arthritis and Crohn’s disease, for protection against cancer, or to decrease nausea or anxiety. CBD products also demonstrate anti-inflammatory properties.
Brazilian government's position on the import of CBD products for the medical purposes perhaps shows that the trend of medical cannabis legalization is taking over the whole world. Legalization of marijuana will likely bring significant improvements in public health and may foster economic growth in the countries supporting it.
“Cannabis has been prescribed for many years in the U.S. to post-chemotherapy patients with pain, nausea, and depression,” says Titus. “It is a natural, botanical product with nominal side effects compared to the use of pharmaceutical drugs.”
Latin America has always had a problem with illegal drugs. Over the past decade, many Latin America countries managed to successfully transform this illegal industry into a government-controlled drug system. Uruguay serves a great example of how successful the legalization of cannabis for medical and recreational purposes may be.